Patrick Amstutz
Founder at MOLECULAR PARTNERS AG
Net worth: 3 M $ as of 2024-03-30
Profile
Patrick Amstutz is the founder of Molecular Partners AG, a company founded in 2004, where he holds the title of Chief Executive Officer & Director.
He is currently the Chief Executive Officer & Director at Molecular Partners, Inc. and the President at Swiss Biotech Association since 2017.
Dr. Amstutz has a doctorate degree from the University of Zurich and a graduate degree from the Swiss Federal Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MOLECULAR PARTNERS AG
2.02% | 2023-12-30 | 735,095 ( 2.02% ) | 3 M $ | 2024-03-30 |
Patrick Amstutz active positions
| Companies | Position | Start |
|---|---|---|
| MOLECULAR PARTNERS AG | Founder | 2004-11-22 |
Swiss Biotech Association
 Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | President | 2022-05-02 |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Chief Executive Officer | - |
Training of Patrick Amstutz
| University of Zurich | Doctorate Degree |
| Swiss Federal Institute of Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| Private companies | 2 |
|---|---|
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | Commercial Services |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Health Technology |
- Stock Market
- Insiders
- Patrick Amstutz
